Alto Neuroscience Files 2023 Annual Report

TL;DR

Alto Neuroscience dropped its 2023 10-K. All systems go for pharma prep.

AI Summary

Alto Neuroscience, Inc. filed its 2023 annual report on Form 10-K on March 21, 2024. The company, incorporated in Delaware, is focused on pharmaceutical preparations and is headquartered in Los Altos, California. The filing covers the fiscal year ended December 31, 2023.

Why It Matters

This filing provides a comprehensive overview of Alto Neuroscience's financial performance and business operations for the past fiscal year, which is crucial for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a standard annual financial filing with no immediate red flags or significant new disclosures.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end date of the reporting period.)
• 001-41944 — SEC File Number (Unique identifier for the company's filings with the SEC.)

Key Players & Entities

• Alto Neuroscience, Inc. (company) — Registrant
• 2023 (date) — Fiscal year end
• March 21, 2024 (date) — Filing date
• Delaware (location) — State of incorporation
• Los Altos, CA (location) — Principal executive offices
• 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)

FAQ

From the Filing

0001999480-24-000010.txt : 20240321 0001999480-24-000010.hdr.sgml : 20240321 20240321162604 ACCESSION NUMBER: 0001999480-24-000010 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 37 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240321 DATE AS OF CHANGE: 20240321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41944 FILM NUMBER: 24771749 BUSINESS ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 10-K 1 altoneuroscienceinc-10xk.htm 10-K Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 10-K ___________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-41944 _____________________________________________________ Alto Neuroscience, Inc. (Exact Name of Registrant as Specified in Its Charter) _____________________________________________________ Delaware 83-4210124 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 369 South San Antonio Road Los Altos, CA 94022 (Address of Principal Executive Offices) (Zip Code) (650) 200-0412 Registrant’s telephone number, including area code Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share ANRO New York Stock Exchange Securities registered pursuant to section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o No x Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes o No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer o Accelerated filer o Non-accelerated filer x Smaller reporting company x Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of th